• Savewith a NBCUniversal ProfileCreate your free profile or…
  • Oct. 11, 2025, 8:00 AM EDTBy Alicia Victoria…
  • Palestinians Begin Return Home As Ceasefire Takes Effect
  • Oct. 11, 2025, 8:48 AM EDT / Updated Oct. 11, 2025,…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Diddy sentenced to 50 months after emotional court day

admin - Latest News - October 3, 2025
admin
8 views 20 secs 0 Comments



A judge sentenced Sean “Diddy” Combs to 50 months in prison, fined him $500,000 and ordered five years of supervised release. NBC News’ Chloe Melas reports from outside the courtroom about what the day was like in court.



Source link

TAGS:
PREVIOUS
Oct. 3, 2025, 6:08 PM EDT / Updated Oct. 3, 2025, 6:29 PM EDTBy Gary Grumbach and Mirna AlsharifWASHINGTON — A woman who pleaded guilty to attempting to assassinate Supreme Court Justice Brett Kavanaugh three years ago was sentenced Friday to more than eight years in prison.Sophie Roske, now 29, was arrested near Kavanaugh’s home in June 2022 and told officials at the time that she intended to kill the associate justice, then herself.She appeared in court on Friday for her sentencing in a yellow jail jumpsuit. Members of Kavanaugh’s family as well as Roske’s were present at the sentencing.U.S. District Judge Deborah Boardman sentenced Roske to 97 months in prison — eight years and one month — saying that she felt Roske has shown remorse for her actions. She also ordered Roske, whom she referred to as a transgender woman, to a lifetime of supervised release.“She has taken full responsibility for her actions,” Boardman said before handing down the sentence.In a federal filing last month, Roske’s attorneys referred to her as Sophie Roske, though the case is still captioned by her legal name because she did not ask to recaption the case, her attorneys said.In court on Friday, Coreen Mao, the attorney representing the Department of Justice, argued that the crime was premeditated because Roske had bought weapons on nine different occasions and made Google searches about serial killers and mass shootings. The government requested a 30 year sentence.Mao said that if it were not for the presence of law enforcement by Kavanaugh’s home, Roske, who was 26 at the time, would have gone through with the assassination.“The primary mission was assassination, not suicide,” Mao said.A public defender for Roske, Ellie Marranzini, said her client wanted to kill Kavanaugh then herself, but changed her mind while in the taxi on her way to his house, adding that there is no evidence she saw the U.S. marshals stationed nearby. Roske’s attorneys said the government is minimizing the fact that she stopped and turned herself in by calling 911.Roske’s parents addressed the court on Friday, vouching for their child. Her father, Vernon Roske, said he believes his child “can be a positive and productive member of the community.”“Sophie has never hurt anyone,” Colleen Roske said. “It was completely out of character.”Sophie Roske also addressed the court to apologize to Kavanaugh and express regret for her actions. She said she planned to kill herself after abandoning her original plan to kill Kavanaugh, but received a phone call from her sister that gave her “a renewed sense of hope.”Kavanaugh’s wife and mother were also in the courtroom, as were representatives of the Supreme Court police department, according to a Supreme Court spokesperson.Right before handing down her sentence, Boardman acknowledged the harm done to Kavanaugh and his family.“He and his family should never have to face the fear of threat,” she said, adding that “political violence should never be accepted and should never ever be normalized.”Roske was arrested near Kavanaugh’s home in Chevy Chase, Maryland, on June 8, 2022. She was armed with a handgun, a knife, pepper spray and burglary tools, officials said.Deputy U.S. marshals spotted Roske — dressed in black and carrying a backpack and a suitcase — getting out of a cab in front of Kavanaugh’s house shortly after 1 a.m., according to a criminal complaint. Roske looked at the officers and then started walking down the street and called 911 on herself, the complaint said.Several minutes of the 911 call was played in court Friday. Roske told police that she had come to Maryland from California to hurt Kavanaugh, that she had a gun in her suitcase, was having suicidal thoughts and needed psychiatric help, according to a recording of the call.Roske allegedly told investigators that she decided to target Kavanaugh because she was angry about the possibility that the Supreme Court would overturn Roe v. Wade and about the deadly school shooting in Uvalde, Texas. She said she thought Kavanaugh would loosen gun laws, the complaint said.Roske initially pleaded not guilty in 2022 to attempting to assassinate Kavanaugh, but eventually pleaded guilty earlier this year without reaching a plea agreement with federal prosecutors.Boardman said Roske will be housed in a male-only Bureau of Prisons facility, and says she took that into consideration when considering the severity of the sentence.Boardman mentioned the ongoing litigation related to President Donald Trump’s executive order on transgender federal inmates. The order, which is currently on pause, directs the federal government to only recognize two genders — male and female — to place transgender women in men’s prisons, and cease funding for any gender-affirming medical care for inmates.Gary Grumbach reported from Washington, D.C., and Mirna Alsharif from New York City. If you or someone you know is in crisis, call or text 988, or go to 988lifeline.org, to reach the Suicide & Crisis Lifeline. You can also call the network, previously known as the National Suicide Prevention Lifeline, at 800-273-8255, or visit SpeakingOfSuicide.com/resources.Gary GrumbachGary Grumbach is an NBC News legal affairs reporter, based in Washington, D.C.Mirna AlsharifMirna Alsharif is a breaking news reporter for NBC News.Lawrence Hurley contributed.
NEXT
Costco to sell Ozempic and Wegovy at a large discount
Related Post
September 24, 2025
Sept. 24, 2025, 4:48 AM EDT / Updated Sept. 24, 2025, 4:55 AM EDTBy Alexander Smith and Jean-Nicholas FievetA call between world leaders is usually a carefully choreographed event reserved for talk of war and peace. France’s Emmanuel Macron used his hotline to President Donald Trump to complain about New York traffic.After giving a speech at the United Nations General Assembly on Monday night, Macron found himself stuck behind a police barricade while trying to reach his country’s diplomatic mission in the city. Whereas regular folk may have sat patiently or taken to social media to vent their fury, Macron put aside any tension over their dueling stances on Israel’s war in Gaza and dialed his friend in the White House.“How are you?” Macron was filmed saying into his cellphone. “Guess what? I’m waiting in the street because everything is frozen for you!”He then attempted to use their traffic-chat as an excuse to discuss more weighty matters.“I would love this weekend have a short discussion with Qatar and you on the situation in Gaza,” said the French leader.French President Macron on the phone to President Trump.Document BFMTVAfter the barricade chat, an official traveling with Macron told NBC News that Macron “took the opportunity to call Donald Trump on the phone while walking, for a very warm and friendly conversation that allowed them to discuss several international issues.”It wasn’t possible to hear Trump’s response. NBC News has reached out to the White House for comment.Police officers guarding the barricades appeared somewhat embarrassed at having to block the path of a visiting world leader.“I’m sorry president, I’m really sorry, it’s just that everything’s frozen right now,” one of them said in the video. Macron seemed to joke with them that they could turn a blind eye to him crossing, saying he wanted to “negotiate” with them.He was not the only world leader to suffer such a traffic-related indignity. Earlier in the day, Turkish President Recep Tayyip Erdoğan was also seen held up at the barriers.French media reported that Macron was soon able to complete his journey to the consulate.Beneath the minor traffic-related indignity there was genuine friction between the two leaders this week. Macron had just announced that France would become the latest country to recognize Palestinian statehood — something Trump decried as a reward for Hamas’ terror attack of Oct. 7, 2023.”I think it honors Hamas and you can’t do that because of October 7. You just can’t do that,” Trump told reporters while sitting next to Macron on Tuesday.The French leader retorted that “nobody forgets the 7th of October, but after almost two years of war, what is the result.” He added, “This is not the right the right way to proceed.”Macron added later Tuesday that if Trump wants his long-coveted Nobel Peace Prize then he needs to stop the war in Gaza.”There is one person who can do something about it, and that is the U.S. president,” Macron told France’s BFMTV. “And the reason he can do more than us, is because we do not supply weapons that allow the war in Gaza to be waged. We do not supply equipment that allows war to be waged in Gaza. The United States of America does.”France is the latest European country to formally recognize Palestine as a state, joining the United Kingdom and adding to a growing list of global nations that now numbers more than 145. The United States, along with Germany, Italy, Japan and a handful of others, are firmly in the minority.Macron has sought to cast himself as a Trump-whisperer who can act as a counterweight to the American leader: Someone who gets on with the president personally but is unafraid to stand up for European interests when the need arises.Nevertheless, their relationship has blown hot and cold. Personal interactions have been characterized by uncomfortably long handshakes and macho knee-slapping. And in June, Trump branded Macron as “publicity seeking” leader who “always gets it wrong,” after Macron made comments about his counterpart’s decision to leave the G-7 summit in Canada early.Though he didn’t mention France by name, Trump during his U.N. address told European nations that “your countries are going to hell” because of their “failed experiment of open borders.”Alexander SmithAlexander Smith is a senior reporter for NBC News Digital based in London.Jean-Nicholas FievetJean-Nicholas Fievet is a senior desk editor for NBC News based in London.Reuters contributed.
September 28, 2025
Sept. 28, 2025, 5:00 AM EDTBy Berkeley Lovelace Jr.Last winter, Brian Noonan read online that some doctors were prescribing an obscure drug, typically given to cancer patients, for autism. Curious, he looked into it for his son Benjamin, who had just been diagnosed with autism in October.“We jumped on it,” Noonan said. “It felt right and it made sense.”The medication was leucovorin, also called folinic acid. It’s a synthetic form of vitamin B9 or folate, which the body needs to make healthy blood cells. During pregnancy, folate is important to reduce the risk of birth defects.Last Monday, the drug was thrust into the national spotlight by President Donald Trump in a rambling press conference about autism that mainly focused on the president and Health Secretary Robert F. Kennedy’s claim that taking acetaminophen during pregnancy could cause autism. Trump briefly mentioned that an “existing drug” — referring to leucovorin — may help with certain symptoms of autism. For those in the autism community, leucovorin is not new. Dr. Richard Frye, a behavioral child neurologist in Phoenix has studied leucovorin and autism for two decades. He made clear that it is not a cure for autism and that more research is needed. He does, however, prescribe it to some people with autism.Noonan’s son Benjamin, who is 4 years old, is one of Frye’s patients. “He’s higher functioning,” Noonan said. “He’s verbal, but he really struggled to put together sentences.” Since starting on the medicine, the family believes Benjamin’s speech has improved, though he still has difficulties with hyperactivity and impulsiveness.Still, Noonan added, he’s under no impression that the drug is a miracle pill. Benjamin also attends a behavioral program preparing him for kindergarten, Noonan said, and he plans to enroll him in speech and occupational therapy. “We very, very much understand we’re still taking an experimental medication,” he said. The Noonan family. Benjamin, 4, who has autism, has used leucovorin.Courtesy of Brian NoonanOther families say the drug conferred larger benefits.Ben Blomgren, of Minneapolis, said his 11-year-old son, Josh, had been prescribed leucovorin off-label in February after he was at risk of being kicked out of school, even as they tried behavioral modification methods.“He’s pretty severe,” Blomgren said. “He didn’t have any language skills. He was not toilet trained.” After starting the medication, Blomgren said Josh’s sleep improved, he’s fully toilet trained and he’s stopped running away from them. “It wasn’t overnight, but we saw major improvement,” he said. Yomarie Miranda, of Florida, said she saw improvements in her 7-year-old son Ethan after he started the medication, including following instructions in class.Ethan was prescribed the medication off label earlier this month, she said.“He’s now looking at me when I speak with him. He’s talking more than before with complete sentences,” she said.A highly unusual moveThe Food and Drug Administration first approved leucovorin in the 1980s to help reduce the toxic side effects of certain chemotherapy drugs.In the decades since, researchers have also studied whether it might treat cerebral folate deficiency (CFD), a neurological condition that makes it harder for folate to reach the brain. Some children with autism also have cerebral folate deficiency, which neurologists say can affect speech, mood and behavior. Last Monday, the FDA said it planned to update the drug’s label to include that use.But the agency’s decision, experts say, rests on just a handful of small studies. And despite Trump’s endorsement, the maker of the brand-name version, GSK, has yet to submit an application to the agency to change the label. In a statement, GSK said it will be submitting the request to expand the approval to include cerebral folate deficiency, though the statement does not mention autism. (Because leucovorin is already an FDA-approved drug, doctors have been able to prescribe it “off label” for other uses, though insurance may not cover it.) It’s a highly unusual move for the FDA: pushing a drug for chemotherapy side effects as a therapy for autism without a formal submission and limited evidence.“It’s incredibly irresponsible,” said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. “For 60-plus years, we’ve counted on the FDA to help patients distinguish between products that work and products that don’t work. And here we saw the FDA making an announcement relying on a summary of unclear data and announcing that they had already decided to approve it.”Alycia Halladay, chief science officer at the nonprofit Autism Science Foundation, was frustrated by the implication that this is a breakthrough in autism research.“It’s not like scientists have just been staring at their belly buttons for 20 years, not looking at autism treatments,” Halladay said in an interview earlier this week. “They have, but the standards have been very high to get [treatments] approved.”Andrew Nixon, a spokesperson for the Department of Health and Human Services, which oversees the FDA, said in a statement: “Analysis across 23 publications from 2009-2024 demonstrated the effectiveness for CFD. Overall, 85% of patients experienced some type of clinical benefit including improved speech/communication capabilities.” Nixon’s statement did not mention autism, and he did not respond to follow-up questions.David Mandell, a psychiatry professor at the University of Pennsylvania, said HHS’ claim that 85% of patients experienced a benefit is a “quite a conceptual leap” because it assumes people with cerebral folate deficiency also have autism.Cerebral folate deficiency “is an extremely rare event, and it is accompanied by symptoms of epilepsy, really severe neurodevelopmental problems and some of those symptoms can look like autism, but it’s not,” he said.“I could not think of a single FDA approval that has such weak evidence in the past 20 years,” Mandell added.Frye, the Phoenix neurologist, estimates up to three-quarters of autistic children have antibodies linked to cerebral folate deficiency, based on his research. Other estimates are much lower: Alycia Halladay, chief science officer at the nonprofit Autism Science Foundation, put the rates at roughly 10% to 30%.The studies on leucovorin are small but look interesting, said Dr. Scott Gottlieb, a former FDA commissioner.“It certainly merits follow up,” Gottlieb said.One of the studies was conducted by Frye: a placebo-controlled trial of more than 40 children with the antibodies, published in Molecular Psychiatry in 2018. It found around two-thirds of kids who got the drug saw improvements in verbal communication after 12 weeks. Others saw no changes. The children all had language impairments, as well as a common type of autism that’s not linked to other neurological diseases.Mandell, however, said the results shouldn’t be taken as evidence.“They claim that in certain subgroups of kids in their already small sample, they find these very large effects,” he said, adding that larger-scale trials that establish clear outcomes ahead of time are needed to verify the results. Kesselheim said it’s important for patients to have access to medications that could have a benefit, especially when there is an unmet medical need. But, he said, there are still a number of unanswered questions.“There is no accurate testing for this,” he said. “What are low folate levels? What are normal folate levels? All of that stuff should be worked out.”Frye said he currently uses two methods to assess whether a child has a folate deficiency: a spinal tap — also known as a lumbar puncture — which involves inserting a needle into the lower back to collect fluid from the spinal cord, and a folate receptor antibody test originally developed for pregnant women that isn’t approved by the FDA for diagnosing folate deficiency in children. Edward Quadros, a research professor at SUNY Downstate Health Sciences University who has worked with Frye studying leucovorin for autism, said parents are already trying the drug, including supplement versions, which aren’t regulated and can be dangerous.“By making the FDA approve it, and reputable pharmaceutical companies manufacturing it and selling it, at least it gives you quality dosing,” Quadros said.Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.Aria Bendix contributed.
September 24, 2025
Sept. 24, 2025, 6:17 PM EDTBy Daniel ArkinJimmy Kimmel’s return to late-night television after a brief suspension drew 6.26 million total viewers, according to preliminary Nielsen ratings, making it the show’s highest-performing regularly scheduled episode in over a decade.The robust ratings are remarkable partly because a typical episode of “Jimmy Kimmel Live!” attracts roughly 1.6 million viewers. Disney, which owns ABC, highlighted that the latest episode did not air in 23% of American households. That’s because Nexstar and Sinclair, two major owners of ABC broadcast affiliates, continue to refuse to run the show following Kimmel’s remarks about the assassination of conservative activist Charlie Kirk.Jimmy Kimmel becomes emotional during monologue after returning to air01:57Kimmel had been at the center of a political firestorm for nearly a week after he commented on the political motivations of the man suspected of killing Kirk at an event at Utah Valley University on Sept. 10.“The MAGA gang [is] desperately trying to characterize this kid who murdered Charlie Kirk as anything other than one of them and doing everything they can to score political points from it,” he said on his Sept. 15 show.Investigators had not yet released details about the suspect’s possible motive at the time.Authorities have charged Tyler Robinson, 22, with murder. Utah Gov. Spencer Cox has said the suspect grew up in a conservative household in Utah but later became influenced by what he characterized as “leftist ideology.”Two days after Kimmel’s remarks about MAGA, Federal Communications Commission Chairman Brendan Carr accused him of being part of a “concerted effort to lie to the American people” and threatened to “take action” against Disney at the regulatory level. Disney’s decision to temporarily pull the show drew backlash from Hollywood talent and lawmakers in both parties, stoking a national debate over free speech.In the opening minutes of Tuesday’s episode, Kimmel, 57, passionately defended free speech and mocked President Donald Trump.“This show is not important,” Kimmel said. “What is important is that we get to live in a country that allows us to have a show like this.”He also attempted to smooth tensions.“You understand that it was never my intention to make light of the murder of a young man,” Kimmel said, his voice breaking. “I don’t think there’s anything funny about it.”In less than 24 hours, Kimmel’s opening monologue has netted more than 26 million views across YouTube and other social media platforms, according to Disney.The initial data does not include streaming viewership, Disney said.Nexstar said Wednesday it was “continuing to evaluate the status of” Kimmel’s show.“We are engaged in productive discussions with executives at The Walt Disney Company, with a focus on ensuring the program reflects and respects the diverse interests of the communities we serve,” Nexstar said in a statement.Sinclair struck a similar chord: “Discussions with ABC are ongoing as we evaluate the show’s potential return.”Daniel ArkinDaniel Arkin is a national reporter at NBC News.
September 26, 2025
Former FBI Director James Comey indicted
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved